Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Prestige Consumer Healthcare Inc before investing.

In this article, we go over a few key elements for understanding Prestige Consumer Healthcare Inc’s stock price such as:

• Prestige Consumer Healthcare Inc’s current stock price and volume
• Why Prestige Consumer Healthcare Inc’s stock price changed recently
• Upgrades and downgrades for PBH from analysts
• PBH’s stock price momentum as measured by its relative strength

About Prestige Consumer Healthcare Inc (PBH)

Before we jump into Prestige Consumer Healthcare Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.

Want to learn more about Prestige Consumer Healthcare Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc’s Stock Price as of Market Close

As of May 15, 2024, 4:00 PM, CST, Prestige Consumer Healthcare Inc’s stock price was $66.46.

Prestige Consumer Healthcare Inc is down 7.01% from its previous closing price of $71.47.

During the last market session, Prestige Consumer Healthcare Inc’s stock traded between $70.89 and $71.60. Currently, there are 49.74 million shares of Prestige Consumer Healthcare Inc stock available for purchase.

Unfortunately, Prestige Consumer Healthcare Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Prestige Consumer Healthcare Inc Stock Price History

Prestige Consumer Healthcare Inc’s (PBH) price is currently down 7.39% so far this month.

During the month of May, Prestige Consumer Healthcare Inc’s stock price has reached a high of $72.05 and a low of $63.00.

Over the last year, Prestige Consumer Healthcare Inc has hit prices as high as $75.31 and as low as $52.90. Year to date, Prestige Consumer Healthcare Inc’s stock is up 6.17%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Prestige Consumer Healthcare Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 14, 2024, there were 0 analysts who downgraded Prestige Consumer Healthcare Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Prestige Consumer Healthcare Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Prestige Consumer Healthcare Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Prestige Consumer Healthcare Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Prestige Consumer Healthcare Inc (PBH) by visiting AAII Stock Evaluator.

Relative Price Strength of Prestige Consumer Healthcare Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 14, 2024, Prestige Consumer Healthcare Inc has a weighted four-quarter relative price strength of -0.63%, which translates to a Momentum Score of 61 and is considered to be Strong.

Want to learn more about how Prestige Consumer Healthcare Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Prestige Consumer Healthcare Inc Stock Price: Bottom Line

As of May 15, 2024, Prestige Consumer Healthcare Inc’s stock price is $66.46, which is down 7.01% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Prestige Consumer Healthcare Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.